Cindy Tahl - General Counsel and Secretary at Fate Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel and Secretary
Stock Symbol
FATE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Cindy Tahl - trading volume in the past year for Fate Therapeutics Inc

Holdings reported by Cindy Tahl for Fate Therapeutics Inc

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 425,000 $1.16 M $2.73 Feb 1, 2024 Direct Common Stock
Common Stock 142,361 $622 K $4.37 Jan 9, 2024 Direct

Transactions reported by Cindy Tahl for Fate Therapeutics Inc

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership